Latest stories on CADL
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
Business Insider55 · neutralgeneral
Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Candel Therapeutics: An Overlooked Late-Stage Biotech With Real Potential
Seeking Alpha67 · bullishproduct/pr
Candel Therapeutics Awards Inducement Options as Clinical Pipeline Gains FDA Momentum
MarketChameleon63 · neutralgeneral
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CADL Stock News
StockTitan50 · neutralgeneral
Candel Therapeutics Stock Gains on Launch of Phase 3 Trial for Lung-Cancer Drug
Morningstar63 · neutralproduct/pr
CADL Stock Heads For Biggest Monthly Gains Since December 2024 – Retail Says ‘Our SLS Days Are Coming’
Stocktwits News63 · neutralproduct/pr
Candel Therapeutics Designates Mark Sims as CCO
Yahoo Top55 · neutralgeneral
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer | CADL Stock News
StockTitan56 · neutralproduct/pr
Candel Therapeutics, Inc. (CADL) files 8-K
SEC 8-K50 · neutralgeneral
Candel Therapeutics Updates Employment Agreement with Chief Financial Officer
TipRanks50 · neutralgeneral
Candel Therapeutics, Inc. (CADL) files 8-K
SEC 8-K50 · neutralgeneral
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CADL Stock News
StockTitan50 · neutralgeneral